11
Publications
347
Citations
10
H-Index
2004
Active since
Affiliations
Y Dündar is an author at University of Liverpool specializing in medicine, cancer therapeutics, and oncology.
Top concepts
MedicineOncologyCancer TherapyClinical TrialsRadiation OncologyHealthPathologyLung CancerPharmacologyCancer Research
Publications per year
2004–2016
11
11
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma
Y Dündar, A Bagust, Juliet Hounsome et al. · Health Technology Assessment · 2009 · 43 citations · Full text
Erlotinib for the treatment of relapsed non-small cell lung cancer
C McLeod, A Bagust, Angela Boland et al. · Health Technology Assessment · 2009 · 39 citations · Full text
A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
Gurpreet Ghattaoraya, Y Dündar, Faviel F. González-Galarza et al. · Database · 2016 · 34 citations · Full text
Rows per page
1–5 of 11